Indeed, advanced liver fibrosis characterized by inflammation, injury, and hepatic fibrosis predisposes patients to HCC, suggesting that AXL can be an oncogenic driver in this context [90,91]. The gene discussed is AXL; the disease is Hepatic fibrosis.